Age: 67 Director Since: 2022 Committees: Compensation Current Public Company Directorships: None Experience and Career Highlights: Mr. Spaight has served as an Operating Partner at Arsenal Capital Partners, a private equity firm focused on healthcare and industrial growth companies, since 2016. He currently serves on the board of directors of CellCarta, a provider of specialized research services supporting immunology- and oncology-focused drug development. Mr. Spaight has held multiple executive chair roles at healthcare and life sciences companies, including BioIVT, LLP, a leading provider of biospecimens for drug discovery; OncoHealth, Inc., a provider of oncology utilization management and cancer care support services; and Accumen (now 3DR Labs), a provider of technology-enabled solutions for medical imaging and clinical laboratories. Earlier in his career, Mr. Spaight served as Chairman and Chief Executive Officer of WIL Research, a global contract research organization providing preclinical services to the biopharmaceutical industry, from 2010 to 2016. He also served as President of MDS Pharma Services, a global contract research organization offering services spanning early drug discovery through late-stage clinical trials. In addition, Mr. Spaight held senior executive roles at Fisher Scientific and PerkinElmer. Mr. Spaight has also served as Chairman of the Association of Clinical Research Organizations ( ACRO ) and as a member of its Board of Directors for four years. Mr. Spaight holds an M.B.A. and a B.S. from the University of Michigan. Qualifications: Mr. Spaight brings more than 35 years of leadership experience across the life sciences, diagnostics, and drug development services industries. His extensive operational, commercial, and board leadership experience particularly within contract research and healthcare services organizations provides the Board with deep industry insight and valuable strategic perspective. The Board believes Mr. Spaight is well qualified to serve as a director based on his operational expertise and industry leadership.